Early myositis symptoms may include difficulty rising from a chair, climbing stairs, lifting the arms, standing for long periods, or walking without fatigue. Some people experience muscle pain, repeated falls, swallowing problems, or a distinctive skin rash. Symptoms often develop gradually and may initially be mistaken for aging or reduced fitness.

Myositis diagnosis begins with symptom history, a neurological examination, and muscle-strength testing. Evaluation may include creatine kinase and other blood tests, myositis antibodies, EMG, muscle MRI, and muscle or skin biopsy. Additional testing may assess swallowing, breathing, lungs, or other organs when symptoms suggest broader involvement.

Treatment depends on the specific myositis type, symptom severity, organ involvement, and treatment response. Options may include corticosteroids, steroid-sparing immune medications, IVIG, physical or occupational therapy, exercise planning, assistive devices, and clinical trial evaluation. Inclusion body myositis often requires a different approach because it may not respond like other inflammatory myopathies.

Yes. Myositis can weaken muscles involved in swallowing and breathing, and some inflammatory myopathies may also affect the lungs. Trouble swallowing, choking, unexplained shortness of breath, or rapidly worsening weakness requires prompt medical attention. Severe breathing or swallowing symptoms should be treated as an emergency.

Many patients with inflammatory myositis can improve with appropriate treatment, rehabilitation, and monitoring, but response varies by disease type and severity. Some forms respond to immune therapy, while inclusion body myositis usually progresses differently. Recovery may also depend on treatment timing, muscle damage, swallowing or lung involvement, and overall health.